Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...

The United Kingdom's healthcare regulator on Friday said it had made the world's largest seizure of illegal weight loss ...

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...

They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...

"This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and ...

Dr Reddy's Laboratories has received approval to manufacture and market generic semaglutide, a weight loss drug, once Novo Nordisk's patent expires in 2026.

The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...

In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...

At least 2,000 pens labelled as containing tirzepatide and retatrutide were seized along with tens of thousands of empty pens ...

Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...